New research shows that extreme weight loss and weight gain significantly increase the risk of death in obese individuals with cardiovascular disease.

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

One late-night meal or midnight snack isn't going to derail your weight loss or cause weight gain. Regularly eating late at ...

New research has found for the first time that extreme weight fluctuations in obese individuals with cardiovascular disease ...

New research set to be presented at the European Congress on Obesity (ECO 2025) suggests that marriage significantly ...

This form of exercise is found to be especially beneficial for women and middle-aged and older adults, particularly those ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...